Skip to content
Use caution Drug recall · FDA · Published July 18, 2013

TUMS Recall: Foreign Tablets in Ultra Strength Assorted Berries

GlaxoSmithKline recalls specific lots of TUMS Ultra Strength 1000mg Assorted Berries tablets due to potential contamination with EX TUMS 750mg tablets.

🇺🇸 FDA recall #D-850-2013DrugTUMS ›
Take action

Contact the company

Recalling firmGlaxoSmithKline, LLC.1011 North Arendell Ave · Zebulon, NC 27597-1217
✎ GovInfoNow plain-language explainer

GlaxoSmithKline is recalling specific lots of TUMS Ultra Strength 1000mg Assorted Berries chewable tablets because they may contain foreign EX TUMS Assorted Berries 750mg tablets. This issue affects products distributed nationwide in the U.S. The recall involves approximately 300,480 bottles. Read more at govinfonow.com/recall/46843-glaxosmithkline-llc-recalls-tums-antacid-calcium-supplement-ultra-strength-1000.

Source Summary by GovInfoNow · govinfonow.com/recall/46843-glaxosmithkline-llc-recalls-tums-antacid-calcium-supplement-ultra-strength-1000 · Updated October 13, 2026 · FDA enforcement record: FDA #D-850-2013

Cite this page

“TUMS Recall: Foreign Tablets in Ultra Strength Assorted Berries.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46843-glaxosmithkline-llc-recalls-tums-antacid-calcium-supplement-ultra-strength-1000. Based on FDA recall #D-850-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-850-2013%22&limit=1).

The FDA announced on July 18, 2013, that GlaxoSmithKline LLC voluntarily recalled TUMS Ultra Assorted Berries Chewable Tablets due to the presence of foreign tablets. The agency stated the product may contain EX TUMS Assorted Berries 750mg tablets instead of the labeled 1000mg strength.

How to tell if you have it

  • Brand: TUMS
  • Product: TUMS Ultra Assorted Berries Chewable Tablets, 72 Count
  • NDC: 0135-0181-02
  • Lot codes: 3C11 and 3C11A

The hazard

The recall addresses the presence of foreign tablets in the product. Specifically, bottles labeled as TUMS Ultra Assorted Berries 1000mg Chewable Tablets may contain EX TUMS Assorted Berries 750mg tablets.

Context

GovInfoNow's records show GlaxoSmithKline LLC has 11 other recalls on record since October 8, 2012. Recent similar recalls include a Haleon Tums Antacid Tablets recall for metallic particles (May 28, 2026) and a Golden State Baclofen Tablets recall for foreign tablets risk (November 26, 2025).

How to tell if you have this one

Check your bottle for the label 'TUMS Ultra Assorted Berries 1000mg Chewable Tablets' and look for NDC 0135-0181-02. Verify the lot numbers on the packaging; this recall specifically affects Lot 3C11 and Lot 3C11A.

  • Brand
    TUMS
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your product matches the recalled NDC 0135-0181-02 and lot numbers 3C11 or 3C11A.

  2. Contact Manufacturer

    Since no specific remedy is listed in the record, contact GlaxoSmithKline for further instructions on returns or refunds.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.8 years after the firm started it.

1. Firm started the recall: Jul 18, 201312. FDA classified it Class III: Aug 7, 201323. Published in FDA’s Enforcement Report: Aug 14, 201334. FDA terminated the recall: May 18, 2016420132016
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-850-2013 (July 18, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-850-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA